ANTIHEMOPHILIC FACTOR HUMAN Pharmacologic Class Indexing
- Class set ID
- c1bcf7ce-51ee-4780-aa42-a8539c4c845e
- Version
- 2
- Effective date
- 20180813
- Type
- Indexing - Pharmacologic Class
Mapped DailyMed Labels#
Label, Manufacturer, Effective table| Label | Manufacturer | Effective | SPL version |
|---|
| b8953ff7-3bba-4a0b-a486-f26fb81f05d9 | Takeda Pharmaceuticals America, Inc. | BAXALTA US Inc. | 20250306 | 15 |
| These highlights do not include all the information needed to use WILATE safely and effectively. See full prescribing information for WILATE. WILATE, von Willebrand Factor/Coagulation Factor VIII Complex (Human) Lyophilized Powder for Solution for Intravenous Injection Initial U.S. Approval: 2009 ----------------------------RECENT MAJOR CHANGES------------------- Indication and Usage (1) 12/2023 Dosage and Administration (2.2, 2.3) 11/2024 | Octapharma USA Inc | 20241119 | 23 |
| These highlights do not include all the information needed to use KOĀTE ® safely and effectively. See full prescribing information for KOĀTE. KOĀTE ® , Antihemophilic Factor (Human) Lyophilized Powder for Solution for Intravenous Injection Initial U.S. Approval: 1974 | KEDRION BIOPHARMA, INC. | GRIFOLS THERAPEUTICS LLC | LABORATORIOS GRIFOLS SA | 20231213 | 10 |
| These highlights do not include all the information needed to use KOĀTE ® safely and effectively. See full prescribing information for KOĀTE. KOĀTE ® , Antihemophilic Factor (Human) Lyophilized Powder for Solution for Intravenous Injection Initial U.S. Approval: 1974 | KEDRION BIOPHARMA, INC. | GRIFOLS THERAPEUTICS LLC | LABORATORIOS GRIFOLS SA | 20231212 | 23 |
| These highlights do not include all the information needed to use Wilate safely and effectively. See full prescribing information for Wilate. Wilate, von Willebrand Factor/Coagulation Factor VIII Complex (Human), Powder for Solution, for Intravenous Use Only. Initial U.S. Approval: 2009 | Octapharma Pharmazeutika Produktionsgesellschaft m.b.H. | 20100820 | 12 |